EURETINA announces two retinal research grants

EURETINA announces two retinal research grants
Colin Kerr
Colin Kerr
Published: Saturday, October 3, 2020
Prof Rufino Martins da Silva
EURETINA has announced two research grants at its 20th Virtual Congress. “It is important to remember that the scope of EURETINA stretches far beyond the congress itself,” said EURETINA President Frank Holz announcing the grants. “Each year, we commit to investing in research, through the EURETINA Retinal Medicine Research Funding Call. Now in its second year, this initiative was introduced to support and encourage independent clinical research in the field of retinal medicine. We received a large volume of high-quality applications, which underwent critical review,” he said. Grants have been awarded to the two highest scoring research applications to be funded by EURETINA in the coming year. In 1st Place, the grant was awarded to Prof Rufino Martins da Silva, of AIBILI, Portugal for his project "Metabolomics: An Integrative Tool for Investigating the Pathogenesis of Age-related Macular Degeneration". In 2nd place, Dr Gian Marco Tosi of University of Siena, Italy, was awarded a grant for his research project "The C-type lectin receptor CD93 as a new target in retinal vascular diseases".
Tags: EURETINA research
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...